Charles River Laboratories reported $982.7M in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Agilent USD 1.88B 43M Jun/2026
Align Technology USD 1.02B 40M Sep/2026
Bio-Rad Laboratories USD 656.4M 5.4M Sep/2026
Bruker USD 874M 35.5M Sep/2026
Cardinal Health USD 67.51B 3.81B Sep/2026
Charles River Laboratories USD 982.7M 17.3M Sep/2026
Cigna USD 73.7B 2B Sep/2026
Concord Medical Services Hldg CNY 259.9M 59.28M Dec/2025
CVS Health USD 108.4B 2.3B Sep/2026
Danaher USD 6.55B 254M Sep/2026
Dentsply International USD 836M 62M Sep/2026
Elevance Health USD 51.43B 1.63B Sep/2026
Humana USD 41.16B 270M Sep/2026
Illumina USD 1.17B 10M Sep/2026
Incyte USD 1.56B 110M Sep/2026
Intrexon USD 717K 511K Jun/2024
IQVIA Holdings USD 4.43B 60M Sep/2026
Laboratory Of America USD 3.81B 80M Sep/2026
Lakefront Biotherapeutics EUR 7.11M 5M Sep/2026
Lonza CHF 3.58B 63M Jun/2025
McKesson USD 110.96B 5.58B Sep/2026
Merck EUR 5.63B 200M Sep/2026
Mettler Toledo International USD 1.09B 60M Sep/2026
Novartis USD 14.52B 112M Sep/2026
Pfizer USD 16.6B 1.57B Sep/2026
Quest Diagnostics USD 3.1B 57M Sep/2026
Revvity USD 729M 680K Sep/2026
Thermo Fisher Scientific USD 12.14B 147M Sep/2026
United Therapeutics USD 832.5M 49.2M Sep/2026
UnitedHealth USD 112.69B 694M Sep/2026
Veradigm USD 142.52M 9.38M Dec/2022
Waters USD 1.77B 130M Sep/2026
West Pharmaceutical Services USD 874.5M 2.2M Sep/2026